Regenovue Fine Plus is made of 100% fully cross-linked monophasic hyaluronic acid and is certified to be highly safe. It is designed with an outstanding uniform structure that allows for precise filling of sunken areas in the face when the filler is injected. Neogenesis Co., Ltd. produced 6 types of Regenovue dermal filler ranging from Fine to Sub-Q, including lidocaine and non-lidocaine variations. It works safely and without harmful effects because there are no detectable BDDE residues in the gel filler due to 100% cross-linking of the HA. It has also demonstrated up to 45% higher viscoelasticity than its competitors, resulting in no gel migration when Regenovue Fine Plus is injected into the upper dermis layer of the skin.

Regenovue Fine Plus is one of the Regenovue series’ “Plus” variants, which includes lidocaine in the formulation. The addition of this anesthetic increases the patient’s comfort during administration. Neogenesis ensures the quality and safety of the Regenovue Fine Plus filler by obtaining CE medical-grade certifications and approval from the Ministry of Food and Drug Safety. Regenovue Fine Plus is made from non-animal hyaluronic acid with below 0.015IU/mg endotoxin levels. Its thick and uniform structure is due to Neogenesis’ patented cross-linking processes, specifically TLS (Ten Layers System) and SPLENDOR (Stable Property, Long-lasting Elasticity, Viscosity, and Deformation on Reducing Temperature). TLS is a uniformization procedure that improves a product’s physical characteristics and viscoelasticity. In contrast, SPLENDOR is a temperature control approach that permits dense and stable molecular structures to develop. Regenovue Fine Plus is intended to remove superficial wrinkles in thin, delicate areas, including the periorbital and glabellar lines.

BENEFITS

1. Produces painless procedure due to the lidocaine component in the formulation.
2. Suitable for superficial and fine wrinkles and lines in the face and neck.
3. Promotes skin hydration and balances moisture in the skin.
4. Fills in depressed areas of the skin, especially caved scars.
5. Fully cross-linked hyaluronic acid using less BDDE agent, thus causing minimal to no side effects.
6. Enhances elasticity of the skin.
7. It is a highly viscous gel with a light consistency, ensuring that filler does not migrate to the other tissues and produces more prolonged effects.
8. Easy and convenient injection, allowing for comfortable and stable treatment.

COMPOSITION

Regenovue Fine Plus contains 24mg/mL of cross-linked hyaluronic acid, a natural substance extracted from bacteria, and therefore has no concern about filler residue accumulation. It also has an endotoxin level 99.2% lower than the European Pharmacopoeia recommendation value of 12.5EU/g, so it is safe from immune responses and infections.

It also contains 0.3% Lidocaine and an addition of a phosphate buffer.

TREATMENT AREAS

1. Superficial wrinkles
2. Periorbital lines
3. Glabellar frown lines
4. Worry lines
5. Perioral lines
6. Caved scars

DURATION OF EFFECT

Regenovue Fine Plus dermal filler can produce effects that last 8 to 12 months. Clinical trials have shown that Regenovue Dermal Fillers’ elasticity stays constant for a long duration without significant elastic loss. Immediate results are also guaranteed, as it is visible within 1 to 2 weeks.

PACKAGING & SPECIFICATION

Packaging: 1 x 1.0mL prefilled syringe + 2 sterile needles (27G, 30G) 

Composition: 24mg/mL Hyaluronic acid + 0.3% Lidocaine

Main particle type: Monophasic structure

Injection Depth: Superficial or upper dermis 

Storage: Store the product at 2°C to 25°C. Do not freeze, and keep away from direct sunlight.

Shelf life: 24 months from manufacturing date

Manufacturer: Neogenesis Co., Ltd., South Korea

** Regenovue Fine Plus must be used only by medical professionals and trained aestheticians to prevent untoward adverse reactions and achieve optimal results.